Standout Papers

The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets 2017 2026 2020 2023 665
  1. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets (2017)
    Bertrand Allard, Maria Serena Longhi et al. Immunological Reviews
  2. The adenosine pathway in immuno-oncology (2020)
    Bertrand Allard, David Allard et al. Nature Reviews Clinical Oncology

Immediate Impact

6 by Nobel laureates 21 from Science/Nature 77 standout
Sub-graph 1 of 20

Citing Papers

A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Cancer cell metabolism and antitumour immunity
2024 Standout
1 intermediate paper

Works of Bertrand Allard being referenced

The adenosine pathway in immuno-oncology
2020 Standout
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses
2015
and 6 more

Author Peers

Author Last Decade Papers Cites
Bertrand Allard 1763 1725 1634 42 3.6k
Sandra Pommey 1304 1260 1224 26 3.2k
Dmitriy Lukashev 1862 1002 2026 32 4.4k
Arabella Young 966 2549 1922 46 4.3k
Sergey Apasov 2090 747 1611 29 3.5k
Sergey V. Novitskiy 727 1632 1591 51 3.9k
Paul A. Beavis 1163 3919 3103 59 6.4k
Magis Mandapathil 511 717 1346 47 2.7k
Laurence Buisseret 398 2535 1596 64 3.5k
Diletta Di Mitri 322 962 2141 24 3.1k
Hidefumi Kojima 617 630 1651 38 3.2k

All Works

Loading papers...

Rankless by CCL
2026